New York, NY -- (SBWIRE) -- 09/09/2013 -- Stock Market Leader is a premiere destination for Investors and novice alike who wish to receive information on fast moving stocks and undiscovered companies. Today we have covered following companies – Lithium Exploration Group Inc(OTCMKTS:LEXG),Provectus Pharmaceuticals, Inc.(OTCMKTS:PVCT),Nintendo Co., Ltd (ADR)(OTCMKTS:NTDOY),International Stem Cell Corp(OTCMKTS:ISCO).
Lithium Exploration Group Inc(OTCMKTS:LEXG) stock is at $0.123, down -8.89 percent from its previous close of $0.14. The stock opened the last trading session at $0.13 and touched its highest price point at $0.13. Its lowest price point for the session stood at $0.11.
Stocks graphical chart shows a bearish trend during its last one month’s trading session. It remained negative -18% during the previous three months trade.
Its total trading volume is 683,220.00 shares for the day, in comparison to its average trading volume of 553,186.00 shares. Lithium Exploration Group, Inc., an exploration stage company, engages in the acquisition, exploration, and development of resource properties in Canada. The company explores for lithium and potassium, as well as for calcium, magnesium, iodine, and bromine.
Has LEXG Found The Bottom and Ready To Move Up? Find Out Here
Provectus Pharmaceuticals, Inc.(OTCMKTS:PVCT) stock closed at $0.740, down -1.32 percent from its previous close of $0.66. Its today’s volume is 670,464.00 shares, in comparison to its average trading volume of 220,187.00 shares. The stock opened the session at $0.74 and touched its highest price point at $0.80.
The lowest price point for the stock stood at $0.74 whereas its 52 week price range stands at $0.43 - $0.89. The company has a total of 128.62 million outstanding shares and its total market capitalization is $95.20 million. Its beta value stands at 0.63 times and earnings per share was $--0.10. Provectus Pharmaceuticals, Inc., a development-stage pharmaceutical company, engages in developing pharmaceuticals for oncology and dermatology indications. The company’s product line includes PV-10, a Phase II study completed drug candidate for metastatic melanoma, a Phase I study completed candidate for breast cancer, and a Phase I protocol expansion candidate for liver metastasis; and PH-10, a Phase IIc randomized study initiated drug candidate for the treatment of psoriasis.
Has PVCT Found The Bottom And Ready To Gain Momentum? Find Out Here
Nintendo Co., Ltd (ADR)(OTCMKTS:NTDOY) opened the session at $14.78 and remained in the $14.41 to $14.80 price range during the session. The stock is -4.03 percent lower at $14.51. Volume at the close was at 667,724.00 shares with its average volume being 43,656.00 shares.
The company has a total of 1.02 billion outstanding shares and its total market capitalization is $17.14 billion. Its beta value stands at 0.72 times and earnings per share was $0.37.The stock was a loser in the 5 days activity and slipped about-5.47%. The one month performance of the stock was negative and it plunged more than -11.52%. Nintendo Co., Ltd. engages in developing, manufacturing, and distributing handheld and home console hardware machines and related software worldwide. It offers entertainment products, including Family Computer/NES, Super Famicom/SNES, Nintendo 64, Nintendo GameCube, Wii, and Wii U products.
Why Should Investors Buy NTDOY After the Recent Fall? Just Go Here and Find Out
International Stem Cell Corp(OTCMKTS:ISCO) traded in the range of $0.16 and $0.17 in its previous trading session. The stock recorded the volume of 595,931.00 shares, in comparison to its average daily trading volume of 457,658.00 shares.
Company’s year to date performance remained declining as it lost almost -16.5%. If we look at the last 6 months of trade, that is in the bearish zone with a drop of -40.57%. The stock opened at $0.17 and its closing price for the day was $0.16, up 1.21 percent from its previous close of $0.16. International Stem Cell Corporation, a developmental stage biotechnology company, engages in the development and commercialization of therapeutic, biomedical, and cosmeceutical products in the United States and internationally.
Will ISCO Continue To Move Higher? Find Out Here
About Stock Market Leader:
Stock Market Leader is a premiere destination for Investors and novice alike who wish to receive information on fast moving OTC penny stocks and undiscovered companies. This is a marketing newsletter that releases paid reports on undiscovered companies looking to tell their stories. Most of these companies are considered penny stocks and trade on the Pink Sheet or OTC BB market. Daily alerts could help investors cut their research time as small cap and penny stock alerts are sent that are displaying signs of a potential rally.
Please carefully read this disclaimer. You must understand and agree to the terms, conditions, cautionary statements and disclosures contained in this disclaimer before using or subscribing to the newsletter.
StockMarketLeader.com is engaged in the business of profiling advertising and marketing companies for monetary compensation. The profiles are intended to be stock ideas and not recommendations. All content on the website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly, constitutes a solicitation of the purchase or sale of any securities.
Please Read Full disclaimer at: http://stockmarketleader.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)